# A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

> **NCT00875030** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** artesunate sachets
- **DRUG:** Arsuamoon

## Key facts

- **NCT ID:** NCT00875030
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00875030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00875030, "A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00875030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*